Kincell Bio (Series A)
Funding Details
- Awarder
- RSS - feeds.feedburner.com
- Date Award
- May 26, 2025
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Funding Amount:
- $22,000,000
Company Info
- Company Description
- Kincell Bio engineers cells into therapies. It is a contract development and manufacturing organization (CDMO) focused on supporting innovative companies developing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK and CAR-M programs.
- Market
- Contract Development and Manufacturing Organization (CDMO)
- Location
- Research Triangle Park, North Carolina, USA
- Coinvestors
- NewSpring Capital, Kineticos Life Sciences